medigraphic.com
ISSN 1027-2852 (Electronic)
ISSN 0864-4551 (Print)

2014, Number 4

<< Back Next >>

Biotecnol Apl 2014; 31 (4)

Perinatal screening and data processing with the SUMA® technology in Cuba

Carlos PN, Rego DA, Fernández YJL, Sistachs VV

Language: Spanish
References: 17
Page: 311-316
PDF size: 595.40 Kb.


ABSTRACT

SUMA® technology (Ultra Micro Analytical System) is applied to the pre-natal, neo-natal, epidemiological surveillance and blood certification screenings, thus solving the country’s needs to own diagnostic means to undertake such programs. It is integrated by diagnostic kits, measurement and software equipment leading to procedures and the know-how. In Cuba, perinatal screening is essential for the functioning of the pre-natal and the post-natal programs within the Mother and Child Program. The Pre-natal program is performed to each pregnant woman: Alphafetoprotein to study alterations during pregnancy, Hepatitis B, and HIV to avoid the transmission of these diseases to the fetus or the newly-born. The Post-natal screening detects Congenital Hyperthyroidism, Phenylketonuria, Congenital Adrenal Hyperplasia, Galactosemia, and Biotinidase Insufficiency to each newly-born, thus avoiding mental retardation, or death. Computation Strips Reader Software support (registered by Cecmed) materializes the theoretical fundaments of SUMA® diagnostics; it consists of a tool destined to the analysis, calculus and interpretation of results for the diagnostic kits and the processing of data supplied by the measurement equipment. It is a methodology of our own, implemented in an algorithm, which includes the treatment for the SUMA® technology assays, offers work safety and reliability, thus obtaining a safe diagnostics. The system has allowed several countries, such as México, Venezuela, Colombia, Ecuador, Nicaragua, Bolivia, Argentina, and Angola, among others, may have access to it. Some elements related to the processing of data with SUMA® technology in perinatal screening, and the computation support contributed by technology for such purposes will be discussed in this work.


REFERENCES

  1. Programa Materno Infantil en Cuba. 2010 [Cited 2014 Nov 7]. Available from: http://www.ecured.cu/index.php/Programa_Materno-infantil_en_Cuba

  2. SUMA (sistema ultramicroanalítico). Tecnosuma Internacional S.A. [Internet] La Habana: Centro de Inmunoensayo. 2010 [Cited 2014 Nov 7]. Available from: http://www.tecnosuma.com

  3. Barba J. Tamiz neonatal: una estrategia en la medicina preventiva. Rev Mex Patol Clin. 2004;51(3):130-44.

  4. Dudley RA, Edwards P, Ekins RP, Finney DJ, McKenzie IGM, Raab GM, et al. Guidelines for Immunoassay Data Processing. Clin Chem. 1985;31(8):1264-71.

  5. Roche [Internet]. Basel: Hoffmann-La Roche Ltd. 2014 [Cited 2014 Nov 7]. Available from: http://www.roche.com/ index.htm

  6. Abbott [Internet]. Chicago: Abbott Laboratories. 2014 [Cited 2014 Nov 7]. Available from: http://www.abbott.com.

  7. BIO-RAD [Internet]. Hercules: Bio-Rad Laboratories Inc. 2014 [Cited 2014 Nov 7]. Available from: http://www.bio-rad.com

  8. Perkin Elmer®. [Internet]. Waltham: PerkinElmer Inc. 2014 [Cited 2014 Nov 7]. Available from: http://www.perkinelmer. com

  9. Whitehead TP. Advances in quality control. Adv Clin Chem. 1977;19:175-205.

  10. Steigstra H, Jannsen RTP, Baaenhuijsen H. Combi Scheme: New combined internal / external quality assessment scheme in The Netherlands. Clin Chem 1991;37(7):1196-204.

  11. Hill P, Uldall A, Wilding P. Fundamentals for External Quality Assessment. Prepared by the Committee on Analytical Quality (CAQ) of the Education and Management Division of International Federation Clinical Chemistry (IFCC). Milano, Italia; Julio 1996.

  12. Ferré J. Calibración multivariante en análisis cuantitativo. El modelo directo. Técnicas de Laboratorio. 2004;297:986-9.

  13. Arnold MA , Small GW. N o n i nvasive glucose sensing. Anal Chem. 2005;77:5429-39.

  14. Ferré J, Boqué R. Análisis de componentes principales aplicado a la representación de datos multidimensionales. Técnicas de Laboratorio. 2004;290:214-9.

  15. Borán G, O’Moore R, Grimson W. A new clinical laboratory information system architecture from the OpenLabs project offering advanced services for laboratory staff and users. Clinical Chemistry. 1996;248(1):19-30.

  16. Levy HL, Hermos RJ, Grady GF, editors. Proceedings. III International society for neonatal screening. Boston, Massachusetts; 1996.

  17. Centro para el Control Estatal de Medicamentos, Equipos y Dispositivos Médicos (CECMED) [Internet]. 2014 [Cited 2014 Nov 7]. Available from: http://www. cecmed.cu/




2020     |     www.medigraphic.com